Profil
Tariq Arshad, formerly a Director at Genentech, Inc., XOMA Corp., and Pharmacia, Inc., served as the Global Head-Medical Affairs & Clinical Research at Becton, Dickinson & Co. from 2019 to 2021.
He also held the position of Senior Manager-CNS at Pfizer Inc. from 1997 to 2009 and Head-Clinical & Medical Affairs at Humanigen, Inc. from 2016 to 2018.
Currently, he is the Chief Medical Officer & Senior Vice President at Qualigen Therapeutics, Inc. until 2024.
Anciens postes connus de Tariq Arshad
| Sociétés | Poste | Fin |
|---|---|---|
| QUALIGEN THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 25/02/2024 |
| BECTON, DICKINSON AND COMPANY | Directeur Technique/Scientifique/R&D | 01/01/2021 |
| HUMANIGEN, INC. | Directeur Technique/Scientifique/R&D | 01/01/2018 |
| PFIZER, INC. | Corporate Officer/Principal | 01/02/2009 |
| Pharmacia, Inc. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| HUMANIGEN, INC. | Health Technology |
| XOMA CORPORATION | Health Technology |
| PFIZER, INC. | Health Technology |
| QUALIGEN THERAPEUTICS, INC. | Health Technology |
| BECTON, DICKINSON AND COMPANY | Health Technology |
| Entreprise privées | 2 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Pharmacia, Inc. |
